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Abstract: Two new compounds, badounoids A (1) and B (2), together with 13 known norsesquiterpenes, were isolated from the 
leaves of Croton tiglium L. The structures of the new compounds were established by means of spectroscopic methods. The  
absolute configuration of badounoid B was determined by single-crystal X-ray diffraction analysis. All the known compounds were 
isolated from Croton plants for the first time which added a new chemical facet for this genus. The selected compounds were  
evaluated for their cytostatic activity against several cancer cell lines. None of them was found to be active. 
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Introduction 
The intriguing structures of Euphorbiaceae plants and their 
diverse biological activities have attracted great interest in the 
recent years.1 Croton tiglium L. is a plant belonging to the 
family Euphorbiaceae, its seeds, a well-known traditional  
Chinese medicine have been extensively investigated. So far, 
diterpenoids, alkaloids, flavonoids, and steroids have been 
characterized from the seeds, they were found to have  
antitumor, antiinflammatory, analgesic, and lipid lowering 
effects.2 The leaves of C. tiglium have been used to treat  
diarrhea, tinea, pain, and hurt,3 however, little is known for its 
chemical profiling. During our search for active compounds 
from the leaves, fifteen norsesquiterpenes including two new 
ones were isolated and structurally identified. This paper  
describes their isolation and structural identification. 
 
Results and Discussion 
Badounoid A (1), isolated as colorless gums, had the  
molecular formula C14H20O3 derived from its positive 
HRESIMS at m/z 259.1318 [M + Na]+ (calcd. 259.1310),  
indicating five degrees of unsaturation. The IR spectrum 
showed the absorption bands for hydroxy (3431 cm−1) and 
,-unsaturated carbonyl (1654 cm−1) groups. The 13C NMR 
and DEPT spectra revealed 14 carbon resonances, which are 
four methyl, one oxygenated methylene, four methine, and 
five quaternary carbons (including one oxygenated carbon and 
one carbonyl), indicating that 1 is an analogue of 5. The 1H-1H 
COSY correlation of H-2 ( 6.99)/H-3 ( 6.18), and HMBC 
correlations of H-2, H-3, Me-14/C-4 ( 188.9), Me-14/C-5 ( 
131.3), C-6 ( 161.9), and Me-12/C-1 ( 41.0), C-6 (Figure 1) 
suggested the west part of 1 as shown. The side chain of 1 was 
identified as a substituted isoprenyl group according to the 
following evidence: (i) 1H-1H COSY correlation of H-7 ( 
6.43)/H-8 ( 5.91), (ii) HMBC correlations of H-8, H-10 ( 
3.49), Me-11 ( 1.34)/C-9 ( 74.6). Further, HMBC correlations
of H-7, H-8/C-6 established the linkage of the side chain with 
the ring. The JH-7,H-8 value of 16.3 Hz indicated a trans double 
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bond. The configuration at C-9 still remained unresolved, 
since the stereochemistry determination at the chiral center of 
the conformationally flexible chain is always challengeable. 
Thus, the structure of 1 was deduced as shown, with a trivial 
name badounoid A. 
Badounoid B (2) was isolated as colorless crystals. The  
molecular formula of 2 was determined to be C13H24O3 from 
its HRESIMS at m/z 227.1652 [M  H] (calcd. 227.1647), 
requiring two degrees of unsaturation. The IR spectrum  
displayed the existence of OH (3430 cm−1) and C=C (1638 
cm−1) functionalities. The NMR data of 2 resembled those of 6. 
Interpretation of 1H-1H COSY, HSQC and HMBC spectra of 2 
disclosed that compounds 2 and 6 have the same planar  
structure. The ROESY correlation of H-5/H-7 suggested that 
Me-13 and OH-6 were spacially vicinal. Whereas, the scarcity 
of diagnostic ROESY signals made it difficult to assign the 
relative configuration at C-3. Thus, the configurations at C-3 
and C-9 of flexible side chain were clarified by X-ray  
diffraction using Cu-irradiation (Figure 2), which also allowed 
the assignment of absolute configuration in 2 as 3R, 5R, 6S, 
and 9R. Therefore, the structure of 2 was determined as shown 
and given a name badounoid B. 
The known compounds were identified as 3β-hydroxy-
5α,6α-epoxy-7-megastigmen-9-one (3),4 4,5-dihydroblumenol 
A (4),5 (3S,4R)-3,4-dihydroxy-β-ionone (5),6 (3S,5R,6S,7E,9R)-
3,6-dihydroxy-5,6-dihydro--ionol (6),7 blumenol A (7),5 
grasshopper ketone (8),8 (3R,6R,7E)-3-hydroxy-4,7-
megastigmadien-9-one (9),9 (+)-3-hydroxy-β-ionone (10),10 
(6R,7E)-4,7-megastigmadien-3,9-dione (11),10 (S)-(+)-de-
hydrovomifoliol (12),11 (3S,5R,6S,7E)-3,5,6-trihydroxy-7-
megastigmen-9-one (13),12 corchoionol C (14),13 and (+)-
boscialin (15),14 respectively, by comparison with literature 
data. All these compounds were isolated from this genus for 
the first time. 
Megastigmane norsesquiterpenoids have been widely found 
in the plants. However, their real role in the plants or in drug 
discovery is poorly known. It was reported that this type of 
norsesquiterpene possesses antiinflammatory activity. Whether 
the present isolates being also responsible for the traditional 
uses of the leaves in infectious diseases needs further  
investigation. In this study, the selected compounds (1, 3, 4, 
1214) were evaluated for their cytostatic activity against HL-
60, SMMC-7721, A-549, MCF-7, and SW480 human cancer 
cells, however, all these compounds showed no activity in this 
assay. 
Among these miscellaneous compounds, we noted that the 
position of OH may be at C-3, C-4, C-5, C-6, or C-9.The OH 
group at C-3 is readily oxidized into a ketone when a double 
bond is formed between C-4 and C-5. Likewise, the OH-3 
tends to be eliminated when a ketone occurs at C-4. In this 
sense, we could tentatively conclude that compounds 5, 8, 9, 




General Experimental Procedures. Optical rotations were 
measured with a Jasco P-1020 polarimeter. IR spectra were 
obtained on a Tensor 27 with KBr pellets. UV spectra were 
measured on a Shimadzu UV-2401A spectrophotometer. NMR 
spectra were run on a DRX-500 MHz spectrometer with TMS 
as an internal standard. ESI and HRESIMS were determined 
with Auto Spec-3000 spectrometer. Silica gel (200–300 mesh, 
Qingdao Marine Chemical Co. Ltd., Qingdao, China), 
RP-18 gel (40–63 m; Daiso Co., Osaka, Japan), and Sephadex




δC δH δC δH 
1 41.0, C   37.4, C  
2 160.0, CH 6.99 (d, 9.9) 42.2, CH2 1.38 (m); 1.82 (dd, 14.6, 3.4) 
3 126.2, CH 6.18 (d, 9.9)  67.3, CH 4.11 (m) 
4 188.9, C   36.4, CH2 1.55 (m); 1.69 (m) 
5 131.3, C   29.1, CH 2.26 (m) 
6 161.9, C   77.9, C  
7 125.0, CH 6.43 (d, 16.3)  133.5, CH 5.67 (d, 15.8) 
8 144.2, CH  5.91 (d, 16.3)  133.7, CH 5.74 (dd, 15.8, 5.1) 
9 74.6, C   68.6, CH 4.38 (m) 
10 70.7, CH2 3.49 (s)  23.8, CH3 1.29 (d, 6.4) 
11 24.7, CH3 1.34 (s)  27.1, CH3 1.15 (s) 
12 27.0, CH3 1.27 (s) 25.6, CH3 0.82 (s) 
13 26.9, CH3 1.27 (s)  15.8, CH3 0.75 (d, 6.8) 
14 13.3, CH3 1.94 (s)    
aData were recorded at 500 MHz for 1H NMR and 125 MHz for 13C NMR.
 
Figure 1.  Selected HMBC (H→C) and COSY(－) correlations 
of 1. 
 
Figure 2.  X-ray crystallographic structure of 2 showing the 
absolute configuration. 
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LH-20 (Amersham Biosciences, Uppsala, Sweden) were used 
for column chromatography (CC). 
 
Plant Material. The leaves of C. tiglium were collected 
from Hubei Province, China, in July 2009. The material was 
identified by Prof. X. Zhou at Hunan University of Chinese 
Medicine. A voucher specimen (CHYX-0488) is deposited at 
the State Key Laboratory of Phytochemistry and Plant  
Resources in West China of our institute. 
 
Extraction and Isolation. The air dried and powdered 
leaves of C. tiglium (75 Kg) were extracted with 80% EtOH (3 
× 100 L) at 60°C and concentrated to give a crude extract (22 
Kg), which was suspended in H2O and passed through a D101 
macroporous resin column eluting with gradient aqueous 
EtOH. The 30% aq. EtOH portion (2 Kg) was fractionated by 
a silica gel CC eluted with CHCl3 with increasing amounts of 
MeOH to afford fractions 1–3. The 50% aq. EtOH portion (2 
Kg) was divided on silica gel eluted with gradient 
CHCl3/MeOH (100:1–1:1) to afford fractions 4–7. The 70% aq. 
EtOH portion (2 Kg) was submitted to a silica gel CC  
eluted with gradient CHCl3/EtOAc to afford fractions 8–10.  
Fraction 1 (280 g) was separated on a silica gel CC eluted with 
CHCl3/Me2CO (15:1 to 5:1) and then subjected to Sephadex 
LH-20 (MeOH) to yield 3 (50 mg), 4 (10 mg) and 5 (6 mg). 
Fraction 2 (460 g) was submitted to a  silica gel CC eluted 
with EtOAc/Me2CO (20:1 to 5:1) followed by RP-18 CC 
(MeOH/H2O, 30:70 to 80:20) to yield 6 (57 mg), 2 (18 mg), 7 
(10 mg) and 8 (10 mg). Fraction 4 (350 g) was separated by 
silica gel CC eluted with CHCl3/Me2CO (10:1 to 5:1) followed 
by RP-18 CC (MeOH/H2O, 20:70 to 80:20) and final purifica-
tion by TLC (CHCl3/i-PrOH, 15:1) to yield 9 (13 mg), 10 (8 
mg), 11 (6 mg) and 12 (23 mg). Fraction 6 (420 g) was  
fractionated by silica gel CC eluted with CHCl3/Me2CO (10:1 
to 4:1) followed by RP-18 CC (MeOH/H2O, 20:70 to 80:20) 
and final purification by Sephadex LH-20 (MeOH) to afford 
13 (17 mg), 1 (21 mg) and 14 (11 mg). Fraction 9 (320 g) was 
separated on silica gel CC eluted with CHCl3/EtOAc (5:1 to 
1:1) and then Sephadex LH-20 (MeOH/CHCl3, 6:4) to yield 
15 (16 mg). 
 
Badounoid A (1): colorless gum; [α]18D   −1.4 (c 0.20 MeOH); 
UV (MeOH) λmax (log ε): 282 (3.28), 235 (3.42); IR (KBr) νmax 
3431, 1654, 1624 cm−1; 1H and 13C NMR data, see Table 1; 
ESIMS m/z 259 [M + Na]+; HRESIMS m/z 259.1318 [M + 
Na]+ (calcd. for C14H20O3Na [M + Na]+, 259.1310). 
 
Badounoid B (2): colorless crystal; [α] 18D   −28.9 (c 0.23 
MeOH); UV (MeOH) λmax (log ε): 201 (2.74); IR (KBr) νmax 
3430, 2925, 1638 cm−1; 1H and 13C NMR data, see Table 1; 
ESIMS m/z 227 [M − H]−; HRESIMS m/z 227.1652 [M − H]− 
(calcd. for C13H23O3 [M − H]−, 227.1647). 
 
Crystallographic Data for Compound 2: C13H24O3, Mr = 
204, Orthorhombic, space group P212121, a = 7.57300(10) Å, b 
= 11.1050(2) Å, c = 16.5082(3) Å, V = 1388.31(4) Å3, Z = 4, 
Dcalcd = 1.179 g cm−3, crystal size 0.33×0.20×0.08 mm3, F (000) 
= 544. The final R1 value is 0.0375 (wR2 = 0.1048) for 7580 
reflections [I > 2σ(I)]. Flack structure parameter 0.2(2). 
The crystallographic data for compound 2 has been  
deposited with the Cambridge Crystallographic Data Centre 
(deposit number CCDC 854477). Copies of the data can be 
obtained, free of charge, on application to the Director, CCDC, 
12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-(0)1223-
336033) or email: deposite@ccdc.cam.ac.uk. 
 
Cytostatic Assay. The cytostatic assay was performed  
using the MTT method, as previous method with slight  
modification.15,16 Briefly, human tumor cells were seeded into 
96-well plates and permitted to adhere for 12 h before drug 
addition. For suspended cells, they were seeded immediately 
before drug addition with an initial density of 12  105 
cells/mL. Each cell line was incubated with different  
concentrations of the compounds for 48 h. DDP and taxol 
were used as positive controls. Cell viability was measured 
and IC50 values were calculated. 
 
Electronic Supplementary Material 
Supplementary material is available in the online version of 
this article at http://dx.doi.org/ 10.1007/s13659-011-0035-3 
and is accessible for authorized users. 
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